Posted on 11/9/20
Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment . . .
Posted on 11/9/20
Neos Therapeutics Reports Third Quarter 2020 Financial Results
DALLAS and FORT WORTH, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused . . .
Posted on 11/9/20
Intercept Pharmaceuticals Reports Third Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to . . .
Posted on 11/9/20
Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update
NEW YORK and SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 11/9/20
Baudax Bio Reports Third Quarter 2020 Financial Results
MALVERN, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today reported financial results . . .
Posted on 11/9/20
Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people . . .
Posted on 11/9/20
Intra-Cellular Therapies Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central . . .
Posted on 11/9/20
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
WEST CHESTER, Penn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today . . .
Posted on 11/9/20
Galectin Therapeutics Provides Business Update And Reports Financial Results
NORCROSS, Ga., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results . . .
Posted on 11/9/20
Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
NEWTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat . . .
Posted on 11/9/20
Homology Medicines Announces $60 Million Equity Investment from Pfizer
BEDFORD, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Pfizer Inc. (NYSE: PFE) has agreed . . .
Posted on 11/9/20
KBL Merger Corp. IV Acquires 180 Life Sciences
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- KBL Merger Corp. IV (NASDAQ: KBLM), a special purpose acquisition company (SPAC), today announced the successful completion of . . .
Posted on 11/9/20
Rubius Therapeutics Reports Third Quarter 2020 Financial Results
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an . . .
Posted on 11/9/20
Cassava Sciences Reports Third Quarter 2020 Financial Results
AUSTIN, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today reported financial results for . . .
Posted on 11/9/20
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results . . .
Posted on 11/9/20
Provident Healthcare Partners Advises Palmetto Retina Center In Its Partnership With Retina Consultants Of America
Palmetto Retina Center, comprised of five retina specialists across six offices serving South Carolina, has partnered with Retina Consultants of America (RCA), a portfolio company of . . .
Posted on 11/9/20
CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results and business highlights . . .
Posted on 11/9/20
Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the third quarter ended . . .
Posted on 11/9/20
Seres Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today reported financial results from the third quarter ended September 30, 2020, and provided business updates.“Supported by our positive, . . .
Posted on 11/9/20
Decibel Therapeutics Raises $82M Series D
Decibel Therapeutics, a clinical-stage biotechnology company developing novel restorative gene therapeutics to treat hearing loss and balance disorders, today announced the closing of an oversubscribed Series . . .
Posted on 11/9/20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates . . .
Posted on 11/9/20
Genesis Healthcare Reports Third Quarter 2020 Results
KENNETT SQUARE, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating . . .
Posted on 11/9/20
LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
LEXINGTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery . . .
Posted on 11/9/20
Reata Pharmaceuticals Announces Third Quarter 2020 Financial Results
PLANO, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced financial results for the quarter ended September . . .
Posted on 11/9/20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
DEVON, Pa., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, . . .

